Literature DB >> 29345022

Seroprevalence of Helicobacter pylori in Korea: A multicenter, nationwide study conducted in 2015 and 2016.

Jeong Hoon Lee1, Kee Don Choi1, Hwoon-Yong Jung1, Gwang Ho Baik2, Jong Kyu Park3, Sung Soo Kim4, Byung-Wook Kim5, Su Jin Hong6, Hyun Lim7, Cheol Min Shin8, Si Hyung Lee9, Seong Woo Jeon10, Ji Hyun Kim11, Cheol Woong Choi12, Hye-Kyung Jung13, Jie-Hyun Kim14, Suck Chei Choi15, Jin Woong Cho16, Wan Sik Lee17, Soo-Young Na18, Jae Kyu Sung19, Kyung Ho Song20, Jun-Won Chung21, Sung-Cheol Yun22.   

Abstract

BACKGROUND: The Korean College of Helicobacter and Upper Gastrointestinal Research has studied Helicobacter pylori (H. pylori) prevalence since 1998 and found a dynamic change in its prevalence in Korea. The aim of this study was to determine the recent H. pylori prevalence rate and compare it with that of previous studies according to socioeconomic variables.
METHODS: We planned to enroll 4920 asymptomatic Korean adults from 21 centers according to the population distribution of seven geographic areas (Seoul, Gyeonggi, Gangwon, Chungcheong, Kyungsang, Cholla, and Jeju). We centrally collected serum and tested H. pylori serum IgG using a chemiluminescent enzyme immunoassay.
RESULTS: We analyzed 4917 samples (4917/4920 = 99.9%) from January 2015 to December 2016. After excluding equivocal serologic results, the H. pylori seropositivity rate was 51.0% (2414/4734). We verified a decrease in H. pylori seroprevalence compared with previous studies performed in 1998, 2005, and 2011 (P < .0001). The H. pylori seroprevalence rate differed by area: Cholla (59.5%), Chungcheong (59.2%), Kyungsang (55.1%), Jeju (54.4%), Gangwon (49.1%), Seoul (47.4%), and Gyeonggi (44.6%). The rate was higher in those older than 40 years (38.1% in those aged 30-39 years and 57.7% in those aged 40-49 years) and was lower in city residents than in noncity residents at all ages.
CONCLUSIONS: Helicobacter pylori seroprevalence in Korea is decreasing and may vary according to population characteristics. This trend should be considered to inform H. pylori-related policies.
© 2018 The Authors. Helicobacter Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990Helicobacter pylorizzm321990; Korea; prevalence

Mesh:

Year:  2018        PMID: 29345022      PMCID: PMC5900911          DOI: 10.1111/hel.12463

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


INTRODUCTION

Helicobacter pylori (H. pylori) has infected more than half of the world's population1 and is an important cause of gastric cancer, mucosal‐associated lymphoid tissue lymphoma, and peptic ulcer disease.2 Chronic infection with H. pylori is strongly associated with gastric cancer3 the highest incidence of which is observed in Korea, Mongolia, Japan, and China.4 Eradication of H. pylori has thus been attempted in China and Japan to reduce gastric cancer levels.5, 6 Accordingly, determination of the H. pylori prevalence of normal asymptomatic participants is crucial for the establishment of national health policies in these Eastern Asia countries. Nationwide studies of H. pylori prevalence were performed in Korea in 1998, 2005, and 2011.7, 8, 9 Although these studies obtained data from a large number of participants, they had several notable limitations, such as inconsistencies in test methods, uneven study populations, and lack of socioeconomic information. Accordingly, the Korean College of Helicobacter and Upper Gastrointestinal Research has newly performed a nationwide H. pylori prevalence study and compared its results with those of previous studies to compensate for their defects.

METHODS

Study population

Study participants were prospectively enrolled from 21 centers in South Korea from January 2015 to December 2016. These centers are based on seven geographic areas: Seoul (3 centers), Gyeonggi (6 centers), Gangwon (2 centers), Chungcheong (2 centers), Kyungsang (4 centers), Cholla (3 centers), and Jeju province (1 center). All participants were asymptomatic Koreans older than 16 years. Patients with gastrointestinal symptoms such as dyspepsia, regurgitation, and pain or who had history of H. pylori eradication, abdominal surgery, or peptic ulcer were excluded. Informed consent was obtained, and a questionnaire on socioeconomic status was administered by a physician or nurse. The questionnaire included family history of gastric cancer, family income, education status, and habitation pattern in preschool, school, and posthigh school periods. Family history of gastric cancer was confined to parents, siblings, and children. Family income was divided into low (US $10,000 per month). Education status was divided into low (middle school graduate or less), medium (high school graduate or university dropout), and high (university graduate or more). We investigated two aspects of habitation status, geographic area, and type of residence in terms of city or noncity during each life period.

Serologic evaluation

All collected serum was centrally analyzed by a single company (Seegene Medical Foundation, Seoul, Korea). The Immulite 2000® H. pylori IgG system (Diagnostic Product Corporation, Los Angeles, CA, USA) was used to measure anti‐H. pylori IgG. This test consists of a solid‐phase, two‐step chemiluminescent enzyme immunoassay. The sensitivity, specificity, positive predictive value, and negative predictive value of this test are reported as 91%, 100%, 100%, and 71%, respectively.10 We used only positive (≥1.10 U/mL) or negative (<0.9 U/mL) results, and equivocal results (0.9‐1.09 U/mL) were excluded from the analysis.

Statistics

A sample size of 4920 was calculated to obtain a two‐sided 95% confidence interval with a width equal to 0.028, assuming a H. pylori infection rate of 55% based on a previous study.9 We distributed participants into seven geographic areas according to the 2013 population census. Categorical variables were analyzed by the chi‐square test. Multivariable logistic regression was used for the investigation of risk factors for H. pylori seropositivity. We used the Cochran‐Armitage trend test for the comparison of H. pylori seroprevalence among the data published in 1998,7 2005,8 2011,9 and in this study. We only analyzed the results of asymptomatic participants from previous studies. A significance level of P < .05 was applied to all analyses except for multiple comparisons. We used the Bonferroni correction to calculate the P values for multiple comparisons.

RESULTS

Seropositivity of participants and comparison with the results from 1998, 2005, and 2011

We enrolled 4963 asymptomatic participants from 21 centers, and 4917 samples were found to be suitable for the H. pylori IgG test (Figure 1). Among these, 183 samples showed equivocal results. Thus, we acquired 4734 seropositive or seronegative results (Table 1). We found that 51.0% (2414/4734) of the study participants were seropositive.
Figure 1

Study flowchart

Table 1

Baseline characteristics of the study population

n%
Total4734100
Sex
Male193740.9
Female279759.1
Subtotal4734100
Age (y)
16‐19200.4
20‐2968514.5
30‐3988918.8
40‐49111523.6
50‐59122525.9
60‐6960312.7
≥701974.2
Subtotal4734100
Geographic area
Seoul78216.5
Gyeonggi158733.5
Gangwon1593.4
Chungcheong48310.2
Kyungsang113323.9
Cholla51110.8
Jeju791.7
Subtotal4734100
Household income
Low145230.7
Medium265556.2
High62113.1
Subtotal4728100
Education level
Low59312.6
Medium137129.0
High276158.4
Subtotal4725100
Body mass index (kg/m2)
<18.52284.9
18.5‐23.0215145.8
23.0‐25.0107222.8
≥25.0124226.5
Subtotal4693100
Family history of gastric cancer
No436292.2
Yes3697.8
Subtotal4731100
Study flowchart We compared the H. pylori seropositivity of asymptomatic participants among the 1998, 2005, and 2011 studies7, 8, 9 and this study. The overall seropositivity of 51.0% (95% CI: 49.6‐52.4%) in this study represented a significant decrease from 66.9% (95% CI: 65.4‐68.6%) in 1998, 59.6% (95% CI: 58.5‐60.7%) in 2005, and 54.4% (95% CI: 53.5‐55.4%) in 2011 (P < .001) (Figure 2). There was thus a significant decline in seropositivity between each successive study. The arithmetical decrease rates per year were 0.81%, 0.87%, and 0.85% during 1998‐2005, 2005‐2011, and 2011‐2015, respectively.
Figure 2

Comparison of Helicobacter pylori seropositivity with previous data 7, 8, 9 in asymptomatic adult participants in South Korea

Comparison of Helicobacter pylori seropositivity with previous data 7, 8, 9 in asymptomatic adult participants in South Korea Baseline characteristics of the study population

Risk factors for H. pylori seropositivity

Age, body mass index (BMI), geographic area, and education level were significantly associated with H. pylori seropositivity (Table 2). Individuals aged 20‐29 years showed the lowest H. pylori seropositivity (24.2%) and this increased up to 64.3% in those aged 50‐59 years (OR 4.67, 95% CI: 3.71‐5.86). A similar trend was observed according to geographic area (Figure 3). The peak prevalence group was distributed among age groups 40‐49 (Seoul), 50‐59 (Gyeonggi, Chungcheong, and Kyungsang), and 60‐69 (Gangwon, Cholla, and Jeju). Although H. pylori seropositivity was 32.1% (511/1594) in participants younger than 40 years, it was 60.6% (1903/3140) in those 40 or older.
Table 2

Risk factors for Helicobacter pylori seropositivity (multivariable logistic regression)

TotalSeropositive H. pylori Odds ratio95% CI
N%
Total4734241451.0
Sex
Male1937104854.11.000.881.15
Female2797136648.8Ref
Age (y)
16‐1920630.00.850.292.45
20‐2968516624.2Ref
30‐3988933938.11.851.472.31
40‐49111564357.73.823.064.76
50‐59122578864.34.673.715.86
60‐6960337161.54.013.035.30
≥7019710151.32.651.833.83
Geographic area
Seoul78237147.4Ref
Gyeonggi158770844.61.040.861.25
Gangwon1597849.11.230.851.76
Chungcheong48328659.21.331.031.72
Kyungsang113362455.11.461.201.77
Cholla51130459.51.521.191.94
Jeju794354.41.630.992.68
Household income
Low145277853.60.920.731.15
Medium2655130649.20.920.761.11
High62132752.7Ref
Education level
Low59336862.11.210.951.56
Medium137180058.41.231.061.42
High2761124345.0Ref
Body mass index (kg/m2)
<18.52287834.20.910.671.23
18.5‐23.02151101247.0Ref
23.0‐25.0107259155.11.140.971.34
≥25.0124270756.91.171.001.37
Family history of gastric cancer
No4362219950.4Ref
Yes36921458.01.080.861.35

The multivariable logistic regression included 4681 individuals.

Figure 3

Helicobacter pylori seropositivity according to geographic area and age group in South Korea

Risk factors for Helicobacter pylori seropositivity (multivariable logistic regression) The multivariable logistic regression included 4681 individuals. Helicobacter pylori seropositivity according to geographic area and age group in South Korea Participants with a high BMI (≥25.0 kg/m2) showed higher H. pylori seropositivity than those with a relatively normal BMI (18.5‐23.0 kg/m2) (OR 1.17, 95% CI: 1.00‐1.37). Chungcheong, Kyungsang, and Cholla, all located in the southern part of South Korea, showed higher H. pylori seropositivity than Seoul (Figure 4). H. pylori seropositivity rates were below 50% in Seoul and the adjacent provinces (Gyeonggi and Gangwon).
Figure 4

Helicobacter pylori seropositivity in seven geographic areas in South Korea

Helicobacter pylori seropositivity in seven geographic areas in South Korea Participants who had a medium education level showed a 23% increase in H. pylori seropositivity compared with those with a high education level (OR 1.23, 95% CI: 1.06‐1.42). Sex, household income, and family history of gastric cancer had no influence on H. pylori seropositivity in multivariable logistic regression analysis.

Impact of habitation according to life period on H. pylori seropositivity

We investigated H. pylori seropositivity according to habitation type (city vs noncity) and life period (Table 3). Participants who lived in non‐city–city–city circumstances according to life period showed higher H. pylori seropositivity than those who lived in city–city–city circumstances (58.4% vs 46.6%, P < .001). Additionally, participants who lived in city circumstances throughout life showed lower H. pylori seropositivity than those who lived in noncity circumstances throughout life (46.6% vs 62.8%, P < .001) and showed lower H. pylori seropositivity than those with non‐city–non‐city–city circumstances throughout life (46.6% vs 56.9%, P < .001).
Table 3

Helicobacter pylori seropositivity according to habitation type and life period

GroupPreschoolSchool‐ageAfter high schoolN%
1a CityCityCity1381/294646.6
2a NoncityCityCity283/48558.4
3a NoncityNoncityCity428/75256.9
4a NoncityNoncityNoncity290/46262.8
5CityCityNoncity16/3053.3
6CityNoncityCity5/1631.3
7NoncityCityNoncity4/666.7
8CityNoncityNoncity3/560.0

We compared groups 1‐4 by considering the relatively large participant number. A P value less than .008 was considered significant due to multiple comparisons.

Group 1 vs 2, P < .001; group 1 vs 3, P < .001; group 1 vs 4, P < .001; group 2 vs 3, P = .618; group 2 vs 4, P = .164; group 3 vs 4, P = .044.

Helicobacter pylori seropositivity according to habitation type and life period We compared groups 1‐4 by considering the relatively large participant number. A P value less than .008 was considered significant due to multiple comparisons. Group 1 vs 2, P < .001; group 1 vs 3, P < .001; group 1 vs 4, P < .001; group 2 vs 3, P = .618; group 2 vs 4, P = .164; group 3 vs 4, P = .044.

DISCUSSION

The H. pylori seropositivity of Korea in 2015 and 2016 was 51.0%, and we confirmed a decrease in H. pylori seropositivity compared with previous studies (from 66.9% in 1998 to 51.0% in 2015). In general, H. pylori is more prevalent in developing countries and less prevalent in developed countries. Our result agrees with the development status of Korea, whose gross domestic products per capita were $12,000 in 2000 and $27,000 in 2015.11 We found decreased H. pylori seropositivity, particularly in those aged 30‐39 years, compared with the three previous Korean nationwide studies. Previous studies reported seropositivity rates in those aged 30‐39 years of 74%, 49%, and 42% in 1998, 2005, and 2011, respectively. Considering that prevalence in less developed regions may reach 70% or higher, compared with 40% or less in more developed regions,12 our result (38.1%) is the first to be below 40% in those aged 30‐39 years. In addition, there was a large increase in seropositivity from those aged 30‐39 years to those aged 40‐49 years in our present study series. However, the biggest increase was shown from those aged 20‐29 years to those aged 30‐39 years in previous Korean studies. Helicobacter pylori infection and gastric cancer are endemic to Japan and China, as well as Korea.1, 13 Japan has shown a decrease in H. pylori prevalence, similar to Korea. In several birth cohort studies from Japan, Japanese individuals born before 1950 showed a H. pylori prevalence rate of 80%‐90%, but those born during the 1980s showed a H. pylori prevalence of 10%‐20%.14, 15 Recent Japanese studies reported that the H. pylori seropositivity in junior high school students was only 3%‐5%.16, 17 Although we did not analyze the birth cohort effect, our lowest seroprevalence rate was 24% in those aged between 20 and 29 years. Also, the highest prevalence rate was observed in those aged between 50 and 59 years. These trends were shown across all seven geographic areas in South Korea. H. pylori seroprevalence data from China have also shown a decrease, from 60% in 1983 to 45% in 2010.18, 19, 20 Korea might show lower prevalence in the future with improved general hygiene, economic development, and a sustained decrease in prevalence among generations. Although Korea is a small and high internal migration country, we anticipated a geographic difference in H. pylori seropositivity. For the first time among studies of this nature, we distributed the study population among seven geographic areas to adapt to the population census result for H. pylori prevalence in Korea. We found that the capital region (Seoul and Gyeonggi) showed lower H. pylori seropositivity than other areas. This trend was also reported in a previous Korean study in 2011.9 Interestingly, as the distance from the capital region increased, so did the odds ratio of H. pylori prevalence. This may be due to urbanization levels, and we indirectly analyzed this effect according to life period. After the exclusion of groups with a small sample size listed in Table 3, participants who lived in a city throughout their life showed the lowest H. pylori seropositivity. Consistently, a recent Chinese study reported that urban populations had lower rates of H. pylori infection than rural populations.20 In our study, we observed that subjects with higher education level tended to show lower H. pylori prevalence. Considering the increasing proportion of city residence after high school (63.9%, 86.7%, and 96.2% in low, medium, and high education level, respectively) as seen in our study population, this result may be explained by the effect of urbanization. Helicobacter pylori was more prevalent in obese patients (BMI ≥25.0 kg/m2) than in those with a normal BMI range (OR 1.17, 95% CI: 1.00‐1.37). However, other BMI groups showed no difference compared with the normal BMI group. And the association between obesity and H. pylori infection is controversial, and the causality of these associations has not been proven.2, 21, 22 We also investigated the correlation between BMI and residence style after high school (city vs noncity) but observed no significant correlation between the two (data not shown). We found no sex differences in the prevalence of H. pylori (OR 1.00, 95% CI: 0.88‐1.15), but a recent meta‐analysis of 169 studies reported that male sex was associated with a higher prevalence of H. pylori (OR 1.12, 95% CI: 1.09‐1.15).23 Our current study was not designed to determine sex differences and several confounding factors were not assessed (such as smoking history, urinary tract infection history in women, and sex hormones). Our study had some limitations of note. First, there may have been a selection bias. We enrolled asymptomatic participants from tertiary hospitals or their health screening centers. Thus, we may have enrolled more participants with a higher socioeconomic status. Second, there could have been a recall bias. We considered the habitation status of our study patients but this is a relatively subjective parameter and might be recalled incorrectly. Third, although this was a prospective study, the enrollment period was relatively long. However, most participants (91%) were enrolled in 2015. In conclusion, our current multicenter, nationwide study found a decrease in H. pylori seroprevalence in South Korea and a difference in the seroprevalence rate according to geographic area and habitation type. Our findings could be useful as future baseline data or to inform H. pylori‐related policies in Korea.

DISCLOSURES OF INTERESTS

All authors declare no conflicts of interest.
  23 in total

Review 1.  Helicobacter pylori Eradication to Eliminate Gastric Cancer: The Japanese Strategy.

Authors:  Masahiro Asaka; Katsuhiro Mabe; Rumiko Matsushima; Momoko Tsuda
Journal:  Gastroenterol Clin North Am       Date:  2015-07-15       Impact factor: 3.806

2.  Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.

Authors:  P Malfertheiner; F Megraud; C A O'Morain; J P Gisbert; E J Kuipers; A T Axon; F Bazzoli; A Gasbarrini; J Atherton; D Y Graham; R Hunt; P Moayyedi; T Rokkas; M Rugge; M Selgrad; S Suerbaum; K Sugano; E M El-Omar
Journal:  Gut       Date:  2016-10-05       Impact factor: 23.059

3.  Evaluation of three commercial serological tests with different methodologies to assess Helicobacter pylori infection.

Authors:  A van Der Ende; R W van Der Hulst; P Roorda; G N Tytgat; J Dankert
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

4.  A large randomised controlled intervention trial to prevent gastric cancer by eradication of Helicobacter pylori in Linqu County, China: baseline results and factors affecting the eradication.

Authors:  Kai-feng Pan; Lian Zhang; Markus Gerhard; Jun-ling Ma; Wei-dong Liu; Kurt Ulm; Jian-xi Wang; Lei Zhang; Yang Zhang; Monther Bajbouj; Lan-fu Zhang; Ming Li; Michael Vieth; Rui-yong Liu; Michael Quante; Le-hua Wang; Stepan Suchanek; Tong Zhou; Wei-xiang Guan; Roland Schmid; Meinhard Classen; Wei-cheng You
Journal:  Gut       Date:  2015-05-18       Impact factor: 23.059

5.  Helicobacter pylori infection and its related factors in junior high school students in Nagano Prefecture, Japan.

Authors:  Yoshiko Nakayama; Yingsong Lin; Minoru Hongo; Hiroya Hidaka; Shogo Kikuchi
Journal:  Helicobacter       Date:  2016-10-27       Impact factor: 5.753

6.  Global cancer statistics, 2012.

Authors:  Lindsey A Torre; Freddie Bray; Rebecca L Siegel; Jacques Ferlay; Joannie Lortet-Tieulent; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-02-04       Impact factor: 508.702

7.  Seroprevalence of Helicobacter pylori in South Korea.

Authors:  Jeong Yoon Yim; Nayoung Kim; Seung Ho Choi; Young Sun Kim; Kyung Ran Cho; Sun Sin Kim; Geom Seog Seo; Heung Up Kim; Gwang Ho Baik; Chan Soo Sin; Sang Heon Cho; Byung Hee Oh
Journal:  Helicobacter       Date:  2007-08       Impact factor: 5.753

Review 8.  Systematic review of time trends in the prevalence of Helicobacter pylori infection in China and the USA.

Authors:  Peter Nagy; Saga Johansson; Michael Molloy-Bland
Journal:  Gut Pathog       Date:  2016-03-15       Impact factor: 4.181

9.  Declining trends in prevalence of Helicobacter pylori infection by birth-year in a Japanese population.

Authors:  Miki Watanabe; Hidemi Ito; Satoyo Hosono; Isao Oze; Chieko Ashida; Kazuo Tajima; Hisato Katoh; Keitaro Matsuo; Hideo Tanaka
Journal:  Cancer Sci       Date:  2015-10-30       Impact factor: 6.716

10.  Seroprevalence of Helicobacter pylori in Korea: A multicenter, nationwide study conducted in 2015 and 2016.

Authors:  Jeong Hoon Lee; Kee Don Choi; Hwoon-Yong Jung; Gwang Ho Baik; Jong Kyu Park; Sung Soo Kim; Byung-Wook Kim; Su Jin Hong; Hyun Lim; Cheol Min Shin; Si Hyung Lee; Seong Woo Jeon; Ji Hyun Kim; Cheol Woong Choi; Hye-Kyung Jung; Jie-Hyun Kim; Suck Chei Choi; Jin Woong Cho; Wan Sik Lee; Soo-Young Na; Jae Kyu Sung; Kyung Ho Song; Jun-Won Chung; Sung-Cheol Yun
Journal:  Helicobacter       Date:  2018-01-18       Impact factor: 5.753

View more
  12 in total

1.  Effect of gastric cancer screening on long-term survival of gastric cancer patients: results of Korean national cancer screening program.

Authors:  Xuan Quy Luu; Kyeongmin Lee; Jae Kwan Jun; Mina Suh; Kyu-Won Jung; Kui Son Choi
Journal:  J Gastroenterol       Date:  2022-05-14       Impact factor: 7.527

Review 2.  Current guidelines for Helicobacter pylori treatment in East Asia 2022: Differences among China, Japan, and South Korea.

Authors:  Jun-Hyung Cho; So-Young Jin
Journal:  World J Clin Cases       Date:  2022-07-06       Impact factor: 1.534

3.  Seven-day triple therapy is sufficient to eradicate infection caused by Helicobacter pylori without 23S rRNA point mutation.

Authors:  Jung Wook Lee; Su Jin Kim; Cheol Woong Choi; Hyeong Jin Kim; Dae Hwan Kang; Hyung Wook Kim; Su Bum Park; Hyeong Seok Nam; Dae Gon Ryu
Journal:  Medicine (Baltimore)       Date:  2021-05-28       Impact factor: 1.817

4.  Modified quadruple therapy versus bismuth-containing quadruple therapy in first-line treatment of Helicobacter pylori infection in Korea; rationale and design of an open-label, multicenter, randomized controlled trial.

Authors:  Hyun Lim; Chang Seok Bang; Woon Geon Shin; Jae Ho Choi; Jae Seung Soh; Ho Suk Kang; Young Joo Yang; Ji Taek Hong; Suk Pyo Shin; Ki Tae Suk; Jae Jun Lee; Gwang Ho Baik; Dong Joon Kim
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

5.  Evaluating Diagnostic Tests for Helicobacter pylori Infection Without a Reference Standard: Use of Latent Class Analysis.

Authors:  Dong Wook Jekarl; Hyunyu Choi; Ji Yeon Kim; Seungok Lee; Tae Geun Gweon; Hae Kyung Lee; Yonggoo Kim
Journal:  Ann Lab Med       Date:  2020-01       Impact factor: 3.464

6.  Where are we today with Helicobacter pylori infection among healthy children in Saudi Arabia?

Authors:  Abdulrahman A Al-Hussaini; Abdullah N Al Jurayyan; Salman M Bashir; Dayel Alshahrani
Journal:  Saudi J Gastroenterol       Date:  2019 Sep-Oct       Impact factor: 2.485

7.  Long-Term Clinical Outcomes of Gastric MALT Lymphoma: A Nationwide Multicenter Study in Korea.

Authors:  Joon Sung Kim; Jun Chul Park; Jong Yeul Lee; Ji Yong Ahn; Sun Hyung Kang; Hyo-Joon Yang; Su Jin Kim; Moon Kyung Joo; Jae Myung Park
Journal:  Front Oncol       Date:  2021-10-14       Impact factor: 6.244

8.  Seroprevalence of Helicobacter pylori in Korea: A multicenter, nationwide study conducted in 2015 and 2016.

Authors:  Jeong Hoon Lee; Kee Don Choi; Hwoon-Yong Jung; Gwang Ho Baik; Jong Kyu Park; Sung Soo Kim; Byung-Wook Kim; Su Jin Hong; Hyun Lim; Cheol Min Shin; Si Hyung Lee; Seong Woo Jeon; Ji Hyun Kim; Cheol Woong Choi; Hye-Kyung Jung; Jie-Hyun Kim; Suck Chei Choi; Jin Woong Cho; Wan Sik Lee; Soo-Young Na; Jae Kyu Sung; Kyung Ho Song; Jun-Won Chung; Sung-Cheol Yun
Journal:  Helicobacter       Date:  2018-01-18       Impact factor: 5.753

9.  Sex differences in the relationship among alcohol, smoking, and Helicobacter pylori infection in asymptomatic individuals.

Authors:  Wenzhi Wu; Marcis Leja; Vladislav Tsukanov; Zarrin Basharat; Dong Hua; Wandong Hong
Journal:  J Int Med Res       Date:  2020-05       Impact factor: 1.671

10.  Alterations in Gastric Microbial Communities Are Associated with Risk of Gastric Cancer in a Korean Population: A Case-Control Study.

Authors:  Madhawa Gunathilake; Jeonghee Lee; Il Ju Choi; Young-Il Kim; Jaekyung Yoon; Woo Jun Sul; Jihyun F Kim; Jeongseon Kim
Journal:  Cancers (Basel)       Date:  2020-09-14       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.